Variant report
Variant | nsv528046 |
---|---|
Chromosome Location | chr5:101241278-101273651 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4703197 | chr5:101241278-101241279 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs150544838 | chr5:101241333-101241334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532538311 | chr5:101241340-101241341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377710619 | chr5:101241341-101241342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17325968 | chr5:101241351-101241352 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs35794627 | chr5:101241352-101241353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114707341 | chr5:101241388-101241389 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183923272 | chr5:101241425-101241426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139496728 | chr5:101241438-101241439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77849690 | chr5:101241470-101241471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547625956 | chr5:101241501-101241502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565346000 | chr5:101241525-101241526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188660631 | chr5:101241526-101241527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551108911 | chr5:101241586-101241587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs67714679 | chr5:101241592-101241593 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs115530943 | chr5:101241595-101241596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115039180 | chr5:101241613-101241614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568592731 | chr5:101241629-101241630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564847856 | chr5:101241644-101241645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191274805 | chr5:101241652-101241653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143819060 | chr5:101241660-101241661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75903304 | chr5:101241661-101241662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572516760 | chr5:101241715-101241716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546194776 | chr5:101241721-101241722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558315662 | chr5:101241799-101241800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs58330681 | chr5:101241845-101241846 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs543872953 | chr5:101241938-101241939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561738407 | chr5:101241950-101241951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs36069752 | chr5:101241969-101241970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573742287 | chr5:101241976-101241977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111802912 | chr5:101250636-101250637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570521439 | chr5:101250703-101250704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140857642 | chr5:101250716-101250717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374035283 | chr5:101250717-101250718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534763231 | chr5:101250724-101250725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs56358829 | chr5:101250728-101250729 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs373050317 | chr5:101250732-101250733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538963055 | chr5:101250733-101250734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556971834 | chr5:101250744-101250745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115657562 | chr5:101250804-101250805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74600424 | chr5:101250816-101250817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75359382 | chr5:101250868-101250869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572996538 | chr5:101250869-101250870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150089804 | chr5:101250872-101250873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192633911 | chr5:101250921-101250922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184528921 | chr5:101250963-101250964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77372998 | chr5:101250990-101250991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138410221 | chr5:101250996-101250997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563810090 | chr5:101251009-101251010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547910194 | chr5:101251065-101251066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101237600-101241400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr5:101239200-101242000 | Weak transcription | Aorta | Aorta |
3 | chr5:101240400-101241400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr5:101250600-101250800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr5:101250600-101251400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:101250600-101251400 | Enhancers | Brain Germinal Matrix | brain |
7 | chr5:101250800-101251200 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr5:101251000-101251400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr5:101251000-101251800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr5:101251200-101251400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr5:101251200-101251600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr5:101251200-101251800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr5:101251400-101251600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr5:101251400-101251800 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
15 | chr5:101251400-101252000 | Active TSS | A549 | lung |
16 | chr5:101251800-101252000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr5:101264400-101264800 | Enhancers | Colon Smooth Muscle | Colon |
18 | chr5:101265200-101266000 | Enhancers | Rectal Smooth Muscle | rectum |